{"id":"W4394770710","doi":"10.1016/j.eururo.2024.03.031","title":"Re: FGFR Inhibition Augments Anti-PD-1 Efficacy in Murine FGFR3-mutant Bladder Cancer by Abrogating Immunosuppression","year":2024,"lang":"en","type":"letter","venue":"European Urology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Immunosuppression; Mutant; Cancer research; Bladder cancer; Fibroblast growth factor receptor; Urothelial cancer; Fibroblast growth factor; Cancer; Internal medicine; Receptor; Gene","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00119731,0.0006332397,0.0007517507,0.0003562112,0.00129082,0.001536159,0.0009037291,0.01967714,0.006653727],"category_scores_gemma":[0.003656409,0.0003556452,0.001003466,0.0002485197,0.0007370542,0.0006080536,0.0004305922,0.009428653,0.004528079],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003166241,"about_ca_system_score_gemma":0.001586315,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00304384,"about_ca_topic_score_gemma":0.006853047,"domain_scores_codex":[0.9991835,0.0001825743,0.00008649314,0.00008757906,0.0002851448,0.0001747828],"domain_scores_gemma":[0.9988386,0.0005805723,0.0001232439,0.00004160126,0.0002347218,0.0001813201],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0008338185,0.000288272,0.001470757,0.0001086566,0.00007611273,0.006544926,0.00007955122,0.0005328304,0.006552729,0.004486144,0.9446187,0.03440753],"study_design_scores_gemma":[0.0009351098,0.0008403076,0.002778479,0.0001385638,0.0000990488,0.003965764,0.0001240397,0.00256957,0.006194176,0.004549628,0.9777375,0.00006783914],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.01065333,0.003945914,0.0007008092,0.9153378,0.03862951,0.0001263948,0.0004008673,0.000273895,0.02993145],"genre_scores_gemma":[0.0555782,0.003356539,0.001221391,0.7948653,0.05289691,0.0002462193,0.0002877994,0.00008767949,0.0914599],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.01967714,"threshold_uncertainty_score":0.02297282,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01781810995683514,"score_gpt":0.2905615366447539,"score_spread":0.2727434266879188,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}